PharmaShots | Incisive News in 3 Shots

Subscribe Now

the DCGI

Biocon's ALZUMAb (itolizumab) Receives the DCGI's Approval for Emergency Use to Treat Patients with Moderate to Severe COVID-19

Biocon's ALZUMAb (itolizumab) Receives the DCGI's Approval for Emergency Use to Treat Patients with Moderate to Severe COVID-19

July 13, 2020

Mylan's Remdesivir Lyophilized Powder for Injection Receives the DCGI Accelerated Approval for Restricted Emergency Use in COVID-19 Patients in India

Mylan's Remdesivir Lyophilized Powder for Injection Receives the DCGI Accelerated Approval for Restricted Emergency Use in COVID-1...

July 6, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us